- 2025 sales decreased by 4% to €5.49 billion.
- EBITDA before special effects was €529 million.
- Special effects led to a negative result of €-805 million.
- Project PACE aims to reduce costs by €300 million annually.
2025 Financial Performance
Wacker Chemie AG reported a 4% decline in sales for 2025, totaling €5.49 billion, compared to €5.72 billion in 2024. The Group's EBITDA fell by 43% to €427 million, down from €744 million the previous year. This decline was attributed to lower volumes, reduced prices, and high energy costs in Germany.
Impact of Special Effects
Special effects related to restructuring and valuation adjustments resulted in a negative outcome of €-805 million for the year. These special effects included €103 million in restructuring costs as part of the ongoing Project PACE, which aims to reduce costs by more than €300 million annually.
2026 Outlook
For 2026, WACKER anticipates sales growth in the low single-digit percentage range. The company expects EBITDA to be between €550 million and €700 million, indicating a potential recovery from the previous year's challenges.
